Government approves IMPCL strategic sale to Skymap Pharmaceuticals for Rs 121 crore under competitive bidding as part of India’s disinvestment plan. For the full story, visit the source.
Politics
Centre clears IMPCL disinvestment as Skymap Pharma emerges highest bidder
Government approves IMPCL strategic sale to Skymap Pharmaceuticals for Rs 121 crore under competitive bidding as part of India’s disinvestment plan.
By PTI· BusinessLine· 4 months ago· 2 min read
This summary is sourced from BusinessLine. Read the full article at:BusinessLine